G protein‐coupled receptor family C, group 5, member D (GPRC5D), a member of the G protein‐coupled receptor (GPCR) family, has recently emerged as a promising target for immunotherapy in hematologic malignancies, particularly multiple myeloma. Here, GPRC5D is linked to AL amyloidosis.